(NP (NP (NN Inhibition)) (PP (IN of) (NP-COOD (NP (NN HIV-1) (NN replication)) (CC and) (NP (NN NF-kappa) (NN B) (NN activity)))) (PP (IN by) (NP-COOD (NP (NN cysteine)) (CC and) (NP (NN cysteine) (NNS derivatives)))) (. .))
(S (NP-SBJ (NN HIV-1) (JJ proviral) (NN DNA)) (VP (VBZ contains) (NP (NP (CD two) (VBG binding) (NNS sites)) (PP (IN for) (NP (DT the) (NN transcription) (NN factor) (NN NF-kappa) (NN B))))) (. .))
(S (NP-SBJ (JJ HIV-1-infected) (NNS individuals)) (VP (VBP have) (, ,) (PP (IN on) (NP (NN average))) (, ,) (NP-COOD (NP (NP (ADJP (RB abnormally) (JJ high)) (NNS levels)) (PP (IN of) (NP (NP (NN tumour) (NN necrosis) (NN factor) (NN alpha)) (PRN (-LRB- -LRB-) (NP (NN TNF) (NN alpha)) (-RRB- -RRB-))))) (CC and) (NP (ADJP (RB abnormally) (JJ low)) (NN plasma) (NN cysteine) (NNS levels)))) (. .))
(S (NP-SBJ (PRP We)) (ADVP (RB therefore)) (VP (VBD investigated) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP-COOD (NP (NN cysteine)) (CC and) (NP (JJ related) (NNS thiols)))) (PP (IN on) (NP-COOD (NP (NN HIV-1) (NN replication)) (CC and) (NP (NN NF-kappa) (NN B) (NN expression)))))) (. .))
(S (NP-SBJ (NP (DT The) (NNS experiments)) (PP (IN in) (NP (DT this) (NN report)))) (VP (VBP show) (SBAR (IN that) (S (NP-SBJ-COOD (NP (NN cysteine)) (CC or) (NP (NP (NN N-acetylcysteine)) (PRN (-LRB- -LRB-) (NP (NN NP)) (-RRB- -RRB-)))) (VP (VP-COOD (VP (VBP raise) (NP (NP (DT the) (JJ intracellular) (NN glutathione) (-LRB- -LRB-) (NN GSH) (-RRB- -RRB-) (NN level)) (PP (-NONE- *RNR*-40)))) (CC and) (VP (VBP inhibit) (NP (NP (NN HIV-1) (NN replication)) (PP (-NONE- *RNR*-40))))) (PP-40 (IN in) (NP (ADJP (RB persistently) (JJ infected)) (NP-COOD (NP (NN Molt-4)) (CC and) (NP (NN U937))) (NNS cells))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP-SBJ-102 (NP (NN inhibition)) (PP (IN of) (NP (NN HIV-1) (NN replication)))) (VP (VBZ appears) (VP (RB not) (TO to) (VP (VB be) (ADVP (RB directly)) (VP (VBN correlated) (NP (-NONE- *-102)) (PP (IN with) (NP (NN GSH) (NNS levels))))))) (. .))
(S (NP-SBJ (NP (NN Cysteine)) (CC and) (NP (NN NP))) (ADVP (RB also)) (VP (VBP inhibit) (NP-COOD (NP (NP (NN NF-kappa) (NN B) (NN activity)) (SBAR (IN as) (S (NP-SBJ-41 (-NONE- *)) (VP (VBN determined) (NP (-NONE- *-41)) (PP (IN by) (NP (JJ electrophoretic) (NN mobility) (NN shift) (NNS assays))))))) (CC and) (NP (NP (NP (NP (NN chloramphenicol) (NN acetyl-transferase)) (PRN (-LRB- -LRB-) (NP (NN CAT)) (-RRB- -RRB-))) (NN gene) (NN expression)) (PP (IN under) (NP (NP (NN control)) (PP (IN of) (NP (NP (NN NF-kappa) (NN B) (NN binding) (NNS sites)) (PP (IN in) (NP (JJ uninfected) (NNS cells)))))))))) (. .))
(S (NP-SBJ (DT This)) (VP (VBZ suggests) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN cysteine) (NN deficiency)) (PP (IN in) (NP (JJ HIV-1-infected) (NNS individuals)))) (VP (MD may) (VP-COOD (VP (VB cause) (NP (NP (DT an) (NN over-expression)) (PP (IN of) (NP (ADJP (NN NF-kappa) (JJ B-dependent)) (NNS genes))))) (CC and) (VP (VB enhance) (NP (NN HIV-1) (NN replication)))))))) (. .))
(S (NP-SBJ-42 (NN NP)) (VP (MD may) (VP (VB be) (VP (VBN considered) (NP (-NONE- *-42)) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ HIV-1-infected) (NNS individuals)))))))) (. .))
